Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of Moderate Aerobic Exercise on Body Composition, Biochemical Parameters and Oxidative Damage in Older Women Without and With Metabolic Syndrome.

Journal of functional morphology and kinesiology·2026
Same author

Skeletal muscle mass and overhydration are associated with in-hospital mortality in acute heart failure patients.

Revista da Associacao Medica Brasileira (1992)·2026
Same author

Aryl-Boroxazolidones with Low In Vitro Neurotoxicity and Alleviative Effects on MPTP-Induced Parkinsonism in Mice.

Biomolecules·2026
Same author

Energy-Dense High-Fat/High-Sucrose Diet to Induce Type 2 Diabetes Mellitus in BALB/c Mice Without Genetic Modifications and Chemical Agents.

Biology·2026
Same author

Analysis of the Short- and Long-Term Immune Response in BALB/c Mice Immunized with Total <i>Naegleria fowleri</i> Extract Co-Administered with Cholera Toxin.

Tropical medicine and infectious disease·2026
Same author

Immunoinformatic Design and Immunoprotective Effect of an mCTA1- and Smp145-Based Vaccine Against Naegleria fowleri.

Parasite immunology·2025

Related Experiment Video

Updated: Jun 17, 2026

A Model of Chronic Nutrient Infusion in the Rat
08:18

A Model of Chronic Nutrient Infusion in the Rat

Published on: August 14, 2013

12.8K

Modeling type 2 diabetes in rats by administering tacrolimus.

J C Quintana-Pérez1, F García-Dolores2, A S Valdez-Guerrero1

  • 1Laboratorio de Investigación en Bioquímica Aplicada, Sección de Estudios de Posgrado e Investigación y Departamento de Formación Básica Disciplinaria, Escuela Superior de Medicina, Instituto Politécnico Nacional, Plan de San Luis y Díaz Mirón, Casco de Santo Tomas,Miguel Hidalgo, Ciudad de México, México.

Islets
|March 29, 2022
PubMed
Summary

A new study introduces a low-cost, non-obese rat model for type 2 diabetes using tacrolimus. This model mimics human disease markers, aiding in the development of new diabetes treatments and safer immunosuppressants.

Keywords:
Wistar rathyperglycemiamodeling type 2 diabetespancreatic damagetacrolimus

More Related Videos

A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes
05:18

A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes

Published on: February 17, 2023

4.5K
Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
06:22

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

784

Related Experiment Videos

Last Updated: Jun 17, 2026

A Model of Chronic Nutrient Infusion in the Rat
08:18

A Model of Chronic Nutrient Infusion in the Rat

Published on: August 14, 2013

12.8K
A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes
05:18

A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes

Published on: February 17, 2023

4.5K
Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
06:22

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

784

Area of Science:

  • Endocrinology and Metabolism
  • Pharmacology
  • Animal Models

Background:

  • Type 2 diabetes prevalence is rising globally, with ~422 million cases currently.
  • Existing animal models for type 2 diabetes have limitations, necessitating a better model.
  • Current treatments cannot cure type 2 diabetes or halt its progression.

Purpose of the Study:

  • To evaluate a novel, low-cost, non-obese type 2 diabetes model in Wistar rats.
  • To assess the efficacy of tacrolimus in inducing type 2 diabetes-like pathology.
  • To establish a model for testing new type 2 diabetes therapies and immunosuppressants.

Main Methods:

  • Administered a high daily dose of tacrolimus to Wistar rats for 4 weeks.
  • Monitored biochemical and antioxidant markers before and after treatment.
  • Assessed fasting blood glucose, glucose tolerance, insulin tolerance, cholesterol, and triglyceride levels.

Main Results:

  • Tacrolimus treatment induced hyperglycemia, hypoinsulinemia, and elevated cholesterol/triglycerides.
  • Biochemical markers mimicked those observed in human type 2 diabetes.
  • Pancreatic β-cell function and morphology were altered, correlating with observed pathology.

Conclusions:

  • The tacrolimus-induced Wistar rat model effectively replicates key features of human type 2 diabetes.
  • This model is suitable for evaluating novel type 2 diabetes treatments.
  • The model can aid in designing immunosuppressants that avoid pancreatic damage and diabetes.